January 12-15 | San Francisco Marriott Marquis
January 12-16 | Virtual
IPS HEART
IPS Heart is a privately held cell therapy company founded in 2014 and is advancing its stem cell platform for generation of new skeletal muscle and new cardiac muscle to treat Duchenne Muscular Dystrophy and heart failure.